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Abstract: Using multiplex bead assays to measure urine proteins has a great potential for biomarker discovery, but substances in 
urine (the matrix) can interfere with assay measurements. By comparing the recovery of urine spiked with known quantities of several 
common analytes, this study demonstrated that the urine matrix variably interfered with the accurate measurement of low abundance 
proteins. Dilution of the urine permitted a more accurate measure of these proteins, equivalent to the standard dilution technique when 
the diluted analytes were above the limits of detection of the assay. Therefore, dilution can be used as an effective technique for over-
coming urine matrix effects in urine immunoassays. These results may be applicable to other biological fluids in which matrix compo-
nents interfere with assay performance.
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Introduction
The  measurement  of  cytokines  and  other  low 
abundance proteins using commercially available 
multiplex bead arrays could translate into new diag-
nostic or prognostic markers of disease.1 However, 
the  variability  of  urine  matrix  components  such 
as  organic  compounds,  pH  and  electrolytes  can 
affect antibody binding and assay performance.2 To 
account for these matrix effects, manufacturers of 
multiplex bead array systems have developed stan-
dard sample diluents for plasma, serum, cell culture 
and other biological specimens. No standard diluent 
has been developed for urine and many other bio-
logical   fluids. Instead, manufacturers suggest that 
phosphate buffered saline be used as “urine-like” 
diluent. This approach does not account for the vari-
ability of matrix components in urine compared to 
more stable levels observed in plasma and serum.3 
Standard addition is a technique in which several dif-
ferent concentrations of an analyte being measured 
are added to the sample matrix. The total endog-
enous concentration of the analyte is calculated as 
the intercept from a plot of the signal responses of 
the detector against the spiked protein amounts. To 
improve the measurement of urine proteins using 
a fluorescence-based multiple bead assay, we con-
ducted  a  series  of  experiments:  (1)  to  determine 
the extent of matrix interference in urine and (2) to 
compare dilution versus standard addition methods 
for determining the unknown concentration of the 
proteins in urine samples.
Results
recovery of proteins spiked in different 
urine samples
To determine the degree and variability of inhibition 
of protein measurement in urine, known concentra-
tions of five proteins were spiked into urine samples 
from four patients with kidney disease (acute tubular 
necrosis, prerenal azotemia, and lupus nephritis) and 
wide variability in typical measurable matrix com-
ponents (Fig. 1 and Supplemental Table 1). Standard 
curves for these five proteins were measured using 
a Bioplex multiplex bead array reader from Bio-Rad 
Laboratories  Inc,  using  the  Luminex  100  system 
according  to  the  manufacturer’s  recommendations. 
Recovery of proteins was calculated as the   percentage 
of interpolated protein concentration measured in the 
urine sample relative to the interpolated protein con-
centration  in  sample  buffer.  Resulting  percentages 
reflect both the endogenous concentration of analyte 
and the matrix effect of the fluid. Recovery for the 
proteins in urine was highly variable (between 0.3 
and 195% for MIP1α, for example), even between 
assays (Figs. 1 and 2). These results demonstrate that 
components of the urine matrix differ among urine 
samples  and  variably  interfere  with  the  accuracy 
of measurement of urine proteins in this assay. It is 
interesting to note that there is also variability in the 
effect of matrix between analytes.
recovery of spiked proteins after dilution 
of urine samples
This experiment was designed to test the hypothe-
sis that diluting urine will reduce the matrix effects 
on recovery of proteins. Urine samples were first 
diluted  in  sample  buffer  before  measurement  by 
bead array. In every case but one (MIP1α in urine 
from patient 1), dilution at 1:2 resulted in higher 
and more accurate measurement of the concentra-
tion of the spiked protein. Diluting unspiked urines 
at 1:20 and 1:10 in most cases resulted in the high-
est protein concentration measurements, suggesting 
that diluting matrix in the sample led to an attenu-
ation of the matrix effect observed in an unspiked 
sample.  For  example,  concentrations  of  IL6  and 
IL8 were 0.8 to 71 and 2 to 55 fold higher, respec-
tively,  in  diluted  than  in  the  undiluted  samples. 
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Figure 1. Recovery of five proteins spiked into urine samples from 
patients with kidney disease. Four different urine samples from patients 
with  acute  tubular  necrosis,  prerenal  azotemia,  and  lupus  nephritis 
were spiked with known quantities of each of five analytes. The per-
cent recovery of analyte was calculated by subtracting the measured 
concentration of unspiked urine from the measured concentration of 
urine spiked with standard then dividing by the expected concentra-
tion of that standard (([measured urinespiked] - [measured urineunspiked])/
[expected standard] × 100).
note: results were reported as means ± standard deviations.overcoming the matrix effect in urine biomarkers
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Some diluted   samples did not have concentrations 
higher than those in the undiluted samples, but for 
many of these the concentration measured was so 
low that diluted concentrations were near the limit 
of    quantification.  This  suggests  that  overcoming 
the matrix effect with dilution in samples with very 
low levels of endogenous analyte was ineffective 
because concentrations were diluted to below the 
limit of quantification of the assay (examples include 
MCP1 in urines 2 and 4 and MIP1α in urines 3 
and 4).   Similarly, the percent recovery of protein 
after it was spiked into diluted samples tended to be 
best at the higher levels of dilution (1:10 or 1:20). 
This  effect  was  pronounced  in  IL8,  MIP1α  and 
TNFα (Fig. 2). Therefore, diluting urine appears to 
be an effective way to overcome individual matrix 
effects of different urine samples.
Standard addition for determining protein 
concentrations and comparison with 
concentrations determined in diluted 
samples
To  evaluate  the  values  of  concentration  obtained 
by dilution, we compared them to the gold stan-
dard method for determining concentrations in an 
inhibitory  matrix–standard  addition.4  A  standard 
addition  plot  was  created  by  spiking  urine  sam-
ples with six known concentrations of analyte and 
plotting the concentration of spiked analyte on the 
x-axis and the corresponding fluorescence intensity 
on the y-axis. A line was then fitted to the plot and 
the unknown concentration was then determined as 
minus the   estimated x-intercept (Fig. 3). The result-
ing   concentrations determined by this analysis were 
compared  to  the  concentrations  of  the  unspiked 
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Figure 2. recovery of analytes spiked into urine samples and after dilution. Urine samples from the same four patients in Figure 1 were diluted in sample 
buffer at either neat concentrations or 1:2, 1:5, 1:10 and 1:20. Samples were then spiked with known amounts of five different protein analytes. The percent 
recovery was calculated using the formula from Figure 1.
notes: results were reported as means ± standard deviations.Taylor et al
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samples  diluted  1:10  (Fig.  3).  This  dilution  was 
used because it provided the most consistent resto-
ration of recovery (Fig. 2) without further dilution 
of sample that could result in levels below the limit 
of quantification of the assay. An identity line was 
shown to highlight the similarities in the concentra-
tions obtained for the two techniques, ie, the nearer 
a  point  to  the  identity  line,  the  more  similar  the 
two measured concentrations. The two techniques 
achieved greater agreement for analytes with higher 
concentrations than for those on the lower end of 
the concentration range (around 50 pg/ml or less), 
suggesting  that  measuring  proteins  using  a  dilu-
tion method can be effective for overcoming matrix 
effects in urine when concentrations are above the 
lower limits of detection.
Discussion
This study demonstrates a large amount of variabil-
ity in protein measurements due to the effects of the 
urine matrix. Concerning is that both assay and urine 
elements appear to contribute to this variability. The 
difference in recovery between analytes observed in 
Figure 1 may relate to matrix components masking 
the antibody or analyte epitopes.5 This effect may be 
differential based on the charge and 3-dimensional 
structure of the variable region of the antibody or of 
analyte epitopes. In our study, the matrix interference 
did not disappear with changing the pH or osmolal-
ity of the sample, with addition of milk as a block-
ing agent, or with removal of low molecular weight 
matrix elements with spin columns (data not shown). 
This  has  important  implications  for  validation  of 
immunoassays to measure low abundance proteins 
in  the  urine.  Before  measures  can  be  considered 
validated, assays for all analytes in a multiplex bead 
array must be tested for recovery of spiked standards 
and  the  effectiveness  of  dilution  as  a  method  for 
reducing matrix effects. If this method is not effec-
tive or if analytes are below the limit of detection 
of the assay, standard addition must be used. Similar 
to our findings, a comprehensive international study 
in 12 laboratories using 14 different immunoassays 
(including Luminex-based bead arrays) found that 
the matrix effects of vaginal mucosal fluid, serum, 
and saline on recovery of IL1β and IL6 were large 
and variable across assays and laboratories,2 demon-
strating that the problem of biological fluid matrix 
elements reducing analyte recovery is not isolated to 
urine. Urine is a similarly complex fluid with a large 
variation in matrix content, and it is difficult to deter-
mine the specific components of urine that may inter-
fere with the assay. More applicable to this study, 
Wood et al similarly advocated the use of   dilution to 
  measure IL6 in urine.6
Standard addition is a well-established approach 
for overcoming matrix effects.4,7 However, standard 
addition  is  time  consuming  and  requires  a  larger 
number of measurements per sample. In these experi-
ments, sample dilution was effective when endoge-
nous protein concentrations were well above the limit 
of quantification. Nonetheless, when urine analytes 
are present at concentrations close to the lower limit 
of quantification of the assay, standard addition should 
be used to determine concentrations. This would sug-
gest  that  dilution  would  be  an  effective  means  of 
determining analyte concentration in urine when the 
assay cutoff between cases and controls in any given 
study is well above the lower limit of quantification. 
These findings likely apply to other biological   fluids 
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Figure 3. Comparison of dilution and standard addition techniques for 
overcoming matrix effects. Analyte concentrations from the same four 
urine samples from Figures 1 and 2 were measured by diluting each 
sample 1:10 and by using the standard addition technique. Standard 
addition was performed by spiking several concentrations of analyte into 
neat urine. The inset is an example of how the standard addition tech-
nique is used to determine the concentration of an unknown sample. The 
analyte concentration is calculated as the x-intercept multiplied by -1. 
A line of identity demonstrates how closely (when the diluted concen-
tration of analyte was above the limit of quantification) the dilution and 
standard addition techniques determine analyte concentration for each 
of the four urine samples.
note: results were reported as means ± standard deviations.overcoming the matrix effect in urine biomarkers
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with  matrix  components  that  interfere  with  assay 
performance.
Methods
Urine analyte analysis
Urine  protein  concentrations  were  measured  using 
commercially  available  multiplex  human  cytokine 
assays and a Bioplex multiplex bead array reader from 
Bio-Rad Laboratories Inc, (Hercules, CA) that uses a 
Luminex 100 system (Luminex Corp., Austin, TX). 
As per manufacturer’s suggestion, a diluent contain-
ing PBS (pH 7.4) and 0.5% BSA was used to prepare 
the standards. Prior to analysis, the bead array reader 
was calibrated per manufacturer’s instructions. Urine 
proteins  from  premixed  kits  (Bio-Rad)  analyzed 
were  IL6,  IL8,  monocyte-chemoattractant    factor-1 
(MCP1),  macrophage  inhibitory  protein  (MIP1)α 
and tumor necrosis factor (TNF)α. All results were 
expressed as means of four replicate values. Limits 
of quantification were defined as the lowest and high-
est concentration at which the percent coefficient of 
variation were below 10%. The interpolated lower 
limits of quantification for IL6, IL8, MCP1, MIP1α, 
and TNFα were 1, 9, 13, 8, and 8 pg/ml respectively.
recovery of proteins spiked  
into urine samples
Four urine samples with a large degree of variation 
in  typical  measurable  components  were  chosen  as 
test samples (Na, ,10 to 106 mM; K, 8 to 44 mM; 
Ca, ,2 to 6.5 mg/dl; UUN, ,50 to 1406; Osm, 252 to 
629 mOsm; pH, 4.6 to 7.8; measured by the   Medical 
University  of  South  Carolina  clinical  laboratory; 
  Supplemental Table 2). Each urine sample was spiked 
with a known quantity of the protein standards within 
the measurable range of the standard curve (IL6, 1046; 
IL8, 588; MCP1, 679; MIP1α, 567; TNFα 2294 pg/ml). 
Each analyte and each unspiked and spiked urine sam-
ple were assayed in quadruplicate and averaged.
recovery of proteins after a series  
of dilutions with standard diluent
A series of dilutions of the four urine samples used 
in  experiment  1  were  made  by  diluting  with  the 
diluent used to create the standard curve (PBS/0.5% 
BSA). Samples diluted 1:20, 1:10, 1:5, and neat were 
  analyzed in quadruplicate and averaged. Then, sam-
ples first diluted 1:20, 1:10, 1:5, 1:2 and neat were 
spiked  with  standard  (IL6,  860;  IL8,  693;  MCP1, 
687; MIP1α, 424; TNFα, 2057 pg/ml) and analyzed 
in quadruplicate and averaged.
Standard addition for determining  
protein concentrations
An experiment was designed using standard addition as 
previously described7 to determine the unknown con-
centrations of proteins. Urines 1, 2 and 3 were spiked 
with five levels of standard (2743 to 7 pg/ml), and these 
and an unspiked sample were analyzed in quadrupli-
cate. Regression lines for the points generated for each 
urine and each analyte (added concentration of stan-
dard—x-axis; instrument response—y-axis) were cre-
ated using the resistant least trimmed squares method 
(function ltsreg in the MASS package)8 for R.9
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supplemental Methods for standard 
Addition
For each urine and each analyte, the estimates of 
the slope and intercept were obtained by minimiz-
ing the 13 (for our data) smallest squared residuals, 
and the estimated concentration was obtained as the 
corresponding  x-intercept.  This  resistant  method 
was  selected  following  comparison  with  ordinary 
least squares, robust least squares (function rlm in 
the  MASS  package),  and  a  Tukey-based  method 
(where data points with residuals classified as outli-
ers were omitted.1 By applying the method to the full 
data and again to data excluding the raw sample, a 
percent recovery for the smallest spike amount was 
determined, which, for the resistant method, proved 
more robust to subject variability for more analytes 
(see Supplemental Fig. 1).
Reference
1.  Tukey JW. Exploratory data analysis. Reading, Mass: Addison-Wesley Pub. 
Co.; 1977.
Table s1. Diagnosis and renal function in patients 1–4.
patient # Diagnosis Renal function 
surrogate
90 (1) Acute tubular necrosis Serum Cr 6.0
414 (2) prerenal azotemia Serum Cr 1.8
918 (3) prerenal azotemia Serum Cr 2.2
923 (4) Class V lupus nephritis Serum Cr 5.1
Table s2. Urine components for individual patient urine samples.
Urine 1 (90) Urine 2 (414) Urine 4 (923) Urine 3 (918) pBs 
[0.5%BsA]*
Ca (mg/dl) 6.5 , 2 2 2 0
Ucr (mg/dl) 15 112 210 90 0
K (mM) 7.7 44.2 30.3 24.8 2.7
Na (mM) 106 74 14 , 10 138
UUN (mg/dl) , 50 975 348 1406 0
osm 252 549 273 629 270
ph 7.8 6.7 4.6 5.3 7.4
*Standard diluent, calculated values urines were measured by the central Lab at the Medical University hospital.publish with Libertas Academica and 
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Figure s1. Fitted lines for each of the 4 methods for each subject’s data (for each protein). Also shown in each panel are the concentrations for the raw 
urine sample derived using standard addition obtained by extrapolating each of the fitted lines.
Abbreviation: ls, least squares.